COYA
Price
$5.43
Change
-$0.18 (-3.21%)
Updated
Dec 18, 04:08 PM (EDT)
NTLA
Price
$12.16
Change
-$0.97 (-7.39%)
Updated
Dec 18, 04:25 PM (EDT)
64 days until earnings call
Ad is loading...

COYA vs NTLA

Header iconCOYA vs NTLA Comparison
Open Charts COYA vs NTLABanner chart's image
Coya Therapeutics
Price$5.43
Change-$0.18 (-3.21%)
Volume$581
CapitalizationN/A
Intellia Therapeutics
Price$12.16
Change-$0.97 (-7.39%)
Volume$4.7K
CapitalizationN/A
COYA vs NTLA Comparison Chart
Loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COYA vs. NTLA commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and NTLA is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (COYA: $5.61 vs. NTLA: $13.13)
Brand notoriety: COYA and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 39% vs. NTLA: 104%
Market capitalization -- COYA: $93.73M vs. NTLA: $1.34B
COYA [@Biotechnology] is valued at $93.73M. NTLA’s [@Biotechnology] market capitalization is $1.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both COYA and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 3 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • COYA’s TA Score: 3 bullish, 6 bearish.
  • NTLA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than COYA.

Price Growth

COYA (@Biotechnology) experienced а -8.33% price change this week, while NTLA (@Biotechnology) price change was -10.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.42%, and the average quarterly price growth was +4.21%.

Reported Earning Dates

COYA is expected to report earnings on Nov 06, 2024.

NTLA is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.34B) has a higher market cap than COYA($93.7M). COYA YTD gains are higher at: -24.291 vs. NTLA (-56.937). COYA has higher annual earnings (EBITDA): -11.33M vs. NTLA (-527.52M). NTLA has more cash in the bank: 658M vs. COYA (31.1M). NTLA has higher revenues than COYA: NTLA (43.1M) vs COYA (9.55M).
COYANTLACOYA / NTLA
Capitalization93.7M1.34B7%
EBITDA-11.33M-527.52M2%
Gain YTD-24.291-56.93743%
P/E RatioN/AN/A-
Revenue9.55M43.1M22%
Total Cash31.1M658M5%
Total DebtN/A102M-
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYANTLA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
88%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCLIF0.06N/A
+4.00%
Discovery Lithium Inc.
SCRYY2.430.05
+2.27%
SCOR
MITEY13.870.04
+0.27%
Mitsubishi Estate Co. Ltd.
NGLOY15.410.01
+0.06%
Anglo American plc
FFMGF0.09N/A
-0.33%
First Mining Gold Corp.

COYA and

Correlation & Price change

A.I.dvisor tells us that COYA and KNSA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COYA and KNSA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-0.88%
KNSA - COYA
32%
Poorly correlated
+0.84%
NTLA - COYA
28%
Poorly correlated
-1.87%
IOVA - COYA
27%
Poorly correlated
-0.38%
ENTA - COYA
27%
Poorly correlated
-2.85%
ABOS - COYA
26%
Poorly correlated
-0.51%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-1.87%
VCYT - NTLA
69%
Closely correlated
-2.52%
EDIT - NTLA
68%
Closely correlated
+2.70%
BEAM - NTLA
66%
Loosely correlated
-1.21%
CRSP - NTLA
62%
Loosely correlated
+0.88%
PRME - NTLA
59%
Loosely correlated
-3.00%
More